At the time of writing, Corbus Pharmaceuticals Holdings Inc [CRBP] stock is trading at $45.25, up 3.12%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CRBP shares have gain 6.52% over the last week, with a monthly amount glided 4.02%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Corbus Pharmaceuticals Holdings Inc [NASDAQ: CRBP] stock has seen the most recent analyst activity on June 26, 2024, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $85. Previously, Oppenheimer reaffirmed its Outperform rating on June 03, 2024, and elevated its price target to $80. On May 13, 2024, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $77 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $46 on March 06, 2024. ROTH Capital downgraded its rating to a Neutral and reduced its price target to $3 on September 08, 2020. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on September 08, 2020. In a note dated September 08, 2020, Jefferies downgraded an Hold rating on this stock and revised its target price from $18 to $2.50.
For the past year, the stock price of Corbus Pharmaceuticals Holdings Inc fluctuated between $3.03 and $55.41. Currently, Wall Street analysts expect the stock to reach $69.33 within the next 12 months. Corbus Pharmaceuticals Holdings Inc [NASDAQ: CRBP] shares were valued at $45.25 at the most recent close of the market. An investor can expect a potential return of 53.22% based on the average CRBP price forecast.
Analyzing the CRBP fundamentals
Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -27.71%, Pretax Profit Margin comes in at -25.01%, and Net Profit Margin reading is -25.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -1.35 and Total Capital is -0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.06 points at the first support level, and at 40.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.46, and for the 2nd resistance point, it is at 47.68.
Ratios To Look Out For
It is important to note that Corbus Pharmaceuticals Holdings Inc [NASDAQ:CRBP] has a current ratio of 4.69. As well, the Quick Ratio is 4.69, while the Cash Ratio is 0.56.
Transactions by insiders
Recent insider trading involved Cohen Yuval, Chief Executive Officer, that happened on Jun 18 ’24 when 22938.0 shares were sold. Chief Financial Officer, Moran Sean F. completed a deal on Jun 18 ’24 to sell 1958.0 shares. Meanwhile, Chief Executive Officer Cohen Yuval sold 11103.0 shares on Jun 17 ’24.
